Valuation
- Market cap
- 1,246,990,000
- Revenue TTM
- $260,210,000
- Net income TTM
- $-12,780,000
- PE ratio
- 255.13
- Forward PE
- 240.12
- Profit margin
- -4.91%
- Debt to equity
- 0.00
Trading
- Volume
- 1,245,000
- Avg volume
- 1,459,742
- Day's range
- $20.32 – $20.98
- Shares out
- 61,217,000
- Stochastic %K
- 60%
- Beta
- 2.03
- Analysts
- Strong Sell
- Price target
- $28.46
Company profile
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management program...
Show more
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 888 987 8337
- Website
- https://www.omadahealth.com
- Address
- 611 Gateway Blvd, Suite 120, South San Francisco, United States
Latest news
No headlines yet.